MSU
EW icon

Maple Securities USA’s Edwards Lifesciences EW Stock Holding History

Maple Securities USA’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-17,046
Closed -$405K – 89
2015
Q2 		$405K Buy
+17,046
New +$385K 0.04% 152

Other funds holding EW

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Maple Securities USA's EW Position: Q3 2015 in Review

Maple Securities USA sold out of Edwards Lifesciences (EW) in Q3 2015, closing a stake of 17,046 shares — an estimated $405K sold.

Maple Securities USA first reported a position in EW in Q2 2015 and held it in 1 quarter. The position peaked at $405K in Q2 2015. 568 funds tracked by Wall St. Rank hold EW as of Q3 2015.

  • Maple Securities USA reported no remaining Edwards Lifesciences position as of Q3 2015 after selling out during the quarter.
  • Maple Securities USA sold 17,046 Edwards Lifesciences shares in Q3 2015, an estimated $405K.
  • Maple Securities USA first reported a position in Edwards Lifesciences in Q2 2015 and held it in 1 quarter.
  • Maple Securities USA's Edwards Lifesciences position peaked at $405K in Q2 2015.
  • 568 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Maple Securities USA's 13F filing for Q3 2015, filed 3 Nov 2015.